KalVista Pharmaceuticals, Inc. (KALV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 822.05M |
| Enterprise Value | 744.28M |
| P/E Ratio | -8.36 |
| PEG Ratio | 0.4 |
| Price/Sales Ratio | 12.4 |
| Price/Book Ratio | -503.31 |
| Enterprise/Revenue | 12.88 |
| Enterprise/EBITDA | -12.74 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.19 |
| Operating Margin | -1.21 |
| Return On Assets | -0.41 |
| Return On Equity | -10.57 |
| Revenue | 73.62M |
| Revenue/Share | 2.29 |
| Gross Profit | 67.54M |
| EBITDA | -150.62M |
| Net Income | -164.29M |
| Diluted EPS | -3.23 |
| Total Cash | 300.21M |
| Total Cash/Share | 5.94 |
| Total Debt | 284.21M |
| Total Debt/Equity | -104.83 |
| Current Ratio | 5.58 |
| Book Value Per Share | -0.05 |
| 52-Week Change | 126.32 |
| 52-Week High | 27 |
| 52-Week Low | 9.83 |
| Moving Average 50 Days | 24.43 |
| Moving Average 200 Days | 17.09 |
| Average Volume | 3.63M |
| Shares Outstanding | 53.24M |
| % Held by Institutions | 137.03 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:14 |
| Last Split Date | November 22, 2016 |